Treatment of Atrophic Acne Scars: Topical or intralesional plasma gel?

Department of Dermatology, Faculty of Medicine, Benha University, Grindelstr. 23, 52146, Würselen, Germany. Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Egypt. Dermatology and Andrology, Faculty of Medicine, Benha University, Egypt.

Photodermatology, photoimmunology & photomedicine. 2021
Abstract
BACKGROUND Atrophic post acne scarring is considered to be a therapeutic challenge. OBJECTIVES The aim was to compare the safety and efficacy of A) FCL combined with intradermal injection of plasma gel, B) FCL combined with topical application of plasma gel, and C) FCL monotherapy in the treatment of atrophic postacne scars. METHODS Thirty patients with facial atrophic post-acne scars were enrolled in this study and randomly assigned into one of three groups. All of them underwent 4 treatment sessions at 4-weeks intervals. They were assessed objectively by the quantitative global scarring grading system (GSGS). This system was applied at baseline, and after 1- and 6-month follow-up (FU). Subjective assessments were performed through the global aesthetic improvement scale (GAIS) and level of patient satisfaction. The DLQI questionnaire was employed at the baseline and 6-month FU. RESULTS According to the quantitative GSGS scores, the reductions in group A (68.4%) and group B (63%) scores were comparable and both were significantly higher than that in group C (41.2%) in all steps of evaluation. At 6-month FU, both groups A and B showed further significant improvement while group C did not. Based on the GAIS and patients' satisfaction, there were no significant differences between all groups. The reductions in DLQI scores in groups A and B were comparable, however both were significantly higher than group C (p<0.001). CONCLUSIONS The combination of plasma gel and FCL resurfacing was noticeably outstanding in their efficacy and impact on the patients' quality of life.
Study details
Language : eng
Credits : Bibliographic data from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine